PTH and hydrops fetalis: Another hypothesis to be tested for the potential improvement of the clinical outcome of individuals with HF syndrome, based on the present results on the interaction between PTH and platelets, could be the addition of antiplatelet agents in HF patients with higher PTH concentration.